Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment.
Saved in:
| Title: | Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment. |
|---|---|
| Authors: | Ferrari S; Geneva University Hospital, Geneva, Switzerland., Butler PW; Amgen Inc., Thousand Oaks, California., Kendler DL; University of British Columbia, Vancouver, British Columbia, Canada., Miller PD; Colorado Center for Bone Research, Lakewood, Colorado., Roux C; Paris Descartes University, Paris, France., Wang AT; Amgen Inc., Thousand Oaks, California., Huang S; Amgen Inc., Thousand Oaks, California., Wagman RB; Amgen Inc., Thousand Oaks, California., Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico. |
| Source: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2019 Aug 01; Vol. 104 (8), pp. 3450-3461. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31125092 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ferrari+S%22">Ferrari S</searchLink>; Geneva University Hospital, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Butler+PW%22">Butler PW</searchLink>; Amgen Inc., Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Kendler+DL%22">Kendler DL</searchLink>; University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Miller+PD%22">Miller PD</searchLink>; Colorado Center for Bone Research, Lakewood, Colorado.<br /><searchLink fieldCode="AU" term="%22Roux+C%22">Roux C</searchLink>; Paris Descartes University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Wang+AT%22">Wang AT</searchLink>; Amgen Inc., Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Huang+S%22">Huang S</searchLink>; Amgen Inc., Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Wagman+RB%22">Wagman RB</searchLink>; Amgen Inc., Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Lewiecki+EM%22">Lewiecki EM</searchLink>; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220375362%22">The Journal of clinical endocrinology and metabolism</searchLink> [J Clin Endocrinol Metab] 2019 Aug 01; Vol. 104 (8), pp. 3450-3461. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0375362 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1945-7197 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220021972X%22">0021972X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Endocrinol Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31125092 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1210/jc.2019-00271 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3450 Titles: – TitleFull: Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ferrari S – PersonEntity: Name: NameFull: Butler PW – PersonEntity: Name: NameFull: Kendler DL – PersonEntity: Name: NameFull: Miller PD – PersonEntity: Name: NameFull: Roux C – PersonEntity: Name: NameFull: Wang AT – PersonEntity: Name: NameFull: Huang S – PersonEntity: Name: NameFull: Wagman RB – PersonEntity: Name: NameFull: Lewiecki EM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2019 Aug 01 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1945-7197 Numbering: – Type: volume Value: 104 – Type: issue Value: 8 Titles: – TitleFull: The Journal of clinical endocrinology and metabolism Type: main |
| ResultId | 1 |